RESCUE-HF Trial: Retrograde Delivery of Allogeneic Umbilical Cord Lining Subepithelial Cells in Patients with Heart Failure

Cell therapy is an evolving option for patients with end-stage heart failure. First-generation cell therapy trials have had marginal success. Our goal was to evaluate retrograde delivery of allogeneic umbilical cord subepithelial cells (UCSECs) in patients with heart failure. A prospective open-labe...

Full description

Bibliographic Details
Main Authors: Jorge Tuma, Antonio Carrasco, Jorge Castillo, Carlos Cruz, Alvaro Carrillo, Jose Ercilla, Carlos Yarleque, Jaime Cunza, Courtney E. Bartlett, Amalia A. Winters, Francisco J. Silva, Amit N. Patel M.D., M.S.
Format: Article
Language:English
Published: SAGE Publishing 2016-09-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368915X690314

Similar Items